P1300 EFFICACY AND SAFETY OF DACLATASVIR IN COMBINATION WITH ASUNAPREVIR (DCV+ASV) IN CIRRHOTIC AND NON-CIRRHOTIC PATIENTS WITH HCV GENOTYPE 1B: RESULTS OF THE HALLMARK DUAL STUDY

Autor: Kao, J.-H., Heo, J., Yoffe, B., Sievert, W., Jacobson, I., Bessone, F., Peng, C.-Y., Roberts, S., Yoon, K.T., Kopit, J., Linaberry, M., Noviello, S., Hughes, E., Manns, M.
Zdroj: In Journal of Hepatology April 2014 60(1) Supplement:S527-S528
Databáze: ScienceDirect